Literature DB >> 12576219

Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury.

Christian-Andreas Mueller1, Herrmann J Schluesener, Sabine Conrad, Richard Meyermann, Jan M Schwab.   

Abstract

We analyzed expression of Endothelial Monocyte-Activating Polypeptide II (EMAP II), a proinflammatory, antiangiogenic cytokine in rat brains after stab wound injury and observed a highly significant (p<0.0001) lesional accumulation confined to microglia/macrophages. Maximum numbers were seen at day 5 declining until 21 days after injury. Further, EMAP II(+) microglia/macrophages formed clusters in perivascular Virchow-Robin spaces. Prolonged accumulation of EMAP II(+), ED1(+) microglia/macrophages and increased lesional numbers of EMAP II(+) endothelial/smooth muscle cells during the acute postinjury period might indicate that EMAP II enrich the proinflammatory and antiangiogenic repertoire of effector molecules expressed by activated microglia/macrophages during secondary damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576219     DOI: 10.1016/s0165-5728(02)00427-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Distribution and characterization of tumor-associated macrophages/microglia in rat C6 glioma.

Authors:  Zhi-Ming Zhang; Zicheng Yang; Zhiren Zhang
Journal:  Oncol Lett       Date:  2015-07-24       Impact factor: 2.967

Review 2.  C6 cell line: the gold standard in glioma research.

Authors:  D Giakoumettis; A Kritis; N Foroglou
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

3.  Expression of endothelial monocyte-activating polypeptide II in the rat dental follicle and its potential role in tooth eruption.

Authors:  Dawen Liu; Gary E Wise
Journal:  Eur J Oral Sci       Date:  2008-08       Impact factor: 2.612

4.  P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury.

Authors:  Changping Yao; Anthony J Williams; Andrew K Ottens; X-C May Lu; Ming Cheng Liu; Ronald L Hayes; Kevin K Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

Review 5.  Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury.

Authors:  Elisa Garcia; Jorge Aguilar-Cevallos; Raul Silva-Garcia; Antonio Ibarra
Journal:  Mediators Inflamm       Date:  2016-06-23       Impact factor: 4.711

6.  Brain lesions in septic shock: a magnetic resonance imaging study.

Authors:  Tarek Sharshar; Robert Carlier; Francis Bernard; Céline Guidoux; Jean-Philippe Brouland; Olivier Nardi; Geoffroy Lorin de la Grandmaison; Jérôme Aboab; Françoise Gray; David Menon; Djillali Annane
Journal:  Intensive Care Med       Date:  2007-03-22       Impact factor: 17.440

7.  FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury.

Authors:  Zhiyuan Zhang; Zhiren Zhang; Uwe Fauser; Matthias Artelt; Michael Burnet; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

Review 8.  The leech nervous system: a valuable model to study the microglia involvement in regenerative processes.

Authors:  Françoise Le Marrec-Croq; Francesco Drago; Jacopo Vizioli; Pierre-Eric Sautière; Christophe Lefebvre
Journal:  Clin Dev Immunol       Date:  2013-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.